Clinical Trial

Study on Safety and Efficacy of UCB-MNCs for Radiation-induced Lung Injury

Name: Study on Safety and Efficacy of UCB-MNCs for Radiation-induced Lung Injury — clinical trial record (NCT07177456)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

This study aims to evaluate the safety and efficacy of the umbilical cord blood mononuclear cells (UCB-MNCs) therapy for radiation-induced lung injuryr (RILI) by observing factors related to the therapeutic effect and adverse reactions of UCB-MNCs in treating RILI .

Trial Details

NCT Number	NCT07177456
Lead Sponsor	Zhejiang Cancer Hospital
Conditions	Radiation-induced Lung Injury
Enrollment	10 participants
Start Date	2025-10-01
Primary Completion	2026-10-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-09-17